semaglutide kidney disease lowers UACR in overweight CKD patients Ozempic picks up FDA indication

WHY HAIL MERRY MAKES SENSE FOR GLP-1 USERS Portion-Controlled by Design Our cups are intentionally portioned rich enough to satisfy, small enough to fit seamlessly into a lower-calorie day

A large study published in The BMJ on July 22 reported that adults with type 2 diabetes taking GLP-1 medicines such as semaglutide were more likely to be diagnosed with hair loss than those on other diabetes drugs

10.1016/j.addr.2016.06.005 44 MalhotraS.LijnseT.O'CearbhaillE.BraydenD

Whilst synthetic GLP-1 receptor agonists (such as semaglutide and liraglutide) have gained attention for diabetes and weight management, many people are interested in evidence-based strategies to enhance their body's own GLP-1 production naturally